Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    Open Studies | "Anus Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Conditions: Epidermoid Carcinoma;   Anus
Interventions: Drug: radiochemotherapy;   Drug: Panitumumab
22 Recruiting Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer
Conditions: Anal Basaloid Carcinoma;   Anal Canal Cloacogenic Carcinoma;   Anal Squamous Cell Carcinoma;   Metastatic Anal Canal Carcinoma;   Recurrent Anal Canal Carcinoma;   Stage IIIB Anal Canal Cancer;   Stage IV Anal Canal Cancer
Interventions: Drug: Capecitabine;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment
23 Recruiting New Strategies to Assess Anal Cancer Risk In Women
Conditions: Human Immunodeficiency Virus (HIV);   Human Papillomavirus (HPV)
Interventions: Procedure: Perianal and Digital Anorectal Exam;   Procedure: Cervical Swabs;   Procedure: Anal Swabs;   Procedure: High Resolution Anoscopy (HRA)
24 Recruiting Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
Condition: Gastric Cancers
Intervention:
25 Recruiting Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Conditions: Anal Cancer;   Cervical Cancer;   Lung Cancer;   Lymphoma
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: medical chart review
26 Recruiting The Patient-Driven Self-Navigated Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families
Conditions: Advanced Cancers;   Anal Cancer;   Colorectal Cancer;   Gastrointestinal Cancer
Interventions: Behavioral: Family History Questionnaire;   Behavioral: Web-Based Family Outreach Registry
27 Recruiting Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
Conditions: Anal Carcinoma;   HIV Infection;   Human Papillomavirus Infection
Interventions: Procedure: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
28 Recruiting Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life
Condition: Locally Advanced Anal Canal Cancer
Interventions: Drug: 5Fluorouracile and Mitomycin-C;   Radiation: Simultaneously integrated boost of intensity modulated radiation therapy (SIB-IMRT) by tomotherapy
29 Not yet recruiting Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas
Conditions: Cervical Cancer;   Vulvar Cancer;   Anal Cancer;   Oropharynx Cancer
Intervention: Other: CaptHPV method
30 Recruiting Study of the Prevention of Anal Cancer
Conditions: Human Papillomavirus;   Cancer
Interventions: Procedure: Participants asked questions about recent experiences of anal intercourse in the last six months.;   Procedure: High Resolution Anoscopy
31 Recruiting Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma
Condition: Carcinoma of the Anal Canal
Interventions: Radiation: Pencil Beam scanning Radiation;   Drug: 5-fluorouracil;   Drug: Mitomycin-C
32 Recruiting E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Biological: E7 TCR cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
33 Recruiting HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
Conditions: Human Papillomavirus-Related Carcinoma;   Human Papillomavirus Positive Oropharyngeal Carcinoma;   Human Papillomavirus Positive Cervical Carcinoma;   Human Papillomavirus Positive Anal Carcinoma;   Human Papillomavirus Positive Vulvar Carcinoma;   Human Papillomavirus Positive Penile Carcinoma
Intervention: Genetic: HPV Specific T Cells
34 Recruiting Chemoradiation-Induced Nausea and Emesis: Quality of Life
Conditions: Gastric Cancer;   Pancreatic Cancer;   Cervical Cancer;   Vulvar Cancer;   Endometrial Cancer;   Anal Cancer
Interventions: Behavioral: Interview;   Other: Questionnaire
35 Recruiting Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer
Conditions: Squamous Carcinoma;   Head and Neck Cancer;   Anal Cancer;   Lung Cancer;   Esophageal Cancer;   Cervix Cancer
Intervention:
36 Recruiting Nivolumab and Ipilimumab in Treating Patients With HIV Associated Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Advanced Solid Neoplasm;   Anal Carcinoma;   HIV Infection;   Kaposi Sarcoma;   Lung Carcinoma;   Metastatic Solid Neoplasm;   Unresectable Solid Neoplasm
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
37 Recruiting Cancer Research Repository for Individuals With Cancer Diagnosis, High Risk Individuals, and Individuals With No History of Cancer (Control)
Conditions: Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma;   Breastcancer;   Leukemia;   Melanoma;   Sarcoma;   Unknown Primary Tumor;   Multiple Myeloma;   Ovarian Cancer;   Endometrial Cancer;   Vaginal Cancer
Intervention:
38 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
39 Recruiting Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
Conditions: Anal Squamous Cell Carcinoma;   HIV Infection;   Stage 0 Anal Canal Cancer;   Stage I Anal Canal Cancer
Intervention: Procedure: Therapeutic Conventional Surgery
40 Recruiting Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive Patients
Condition: Anal Intraepithelial Neoplasia (AIN) in HIV-infected Patients
Interventions: Other: Topical 85% trichloroacetic acid (TCA);   Procedure: Surgical electrocautery (ECA)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.